Paul Tudor Jones Pulmonx Corp Transaction History
Tudor Investment Corp Et Al
- $44 Billion
- Q2 2025
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Pulmonx Corp stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 241,051 shares of LUNG stock, worth $424,249. This represents 0.0% of its overall portfolio holdings.
Number of Shares
241,051
Previous 204,818
17.69%
Holding current value
$424,249
Previous $1.38 Million
54.72%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding LUNG
# of Institutions
115Shares Held
33.9MCall Options Held
0Put Options Held
0-
Primecap Management CO Pasadena, CA5.16MShares$9.09 Million0.01% of portfolio
-
Morgan Stanley New York, NY3.56MShares$6.26 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$4.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.29MShares$4.04 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY1.89MShares$3.33 Million0.11% of portfolio
About Pulmonx Corp
- Ticker LUNG
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,268,400
- Market Cap $65.6M
- Description
- Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...